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1 | PLAIN LANGUAGE SUMMARY
1.1 | Cognitive behavioral therapy for anxiety in
school‐aged children with autism spectrum disorder
can reduce anxiety
Cognitive behavioral therapy (CBT) interventions to reduce the level
of anxiety in students with autism spectrum disorder (ASD) are
moderately effective.
1.2 | What is this review about?
Anxiety is a common problem in school‐aged children with ASD. CBT and
other psychosocial interventions have been developed as alternatives to
pharmacological intervention to treat anxiety in students with ASD.
What is the aim of this review?
This Campbell systematic review examines the effects of
interventions for reducing anxiety in school‐aged children
with ASD, compared to treatment‐as‐usual. The review
summarizes evidence from 24 studies using an experi-
mental or quasi‐experimental design.
1.1 | What studies are included?
Twenty‐four studies, involving 931 school‐aged children with ASD
(without co‐occurring intellectual disability) and clinical anxiety, are
summarized in this review. The studies were experimental or quasi‐
experimental control‐treatment trials, deemed to be of sufficient meth-
odological quality and with reduced risk of bias. Studies spanned the
period 2005 to 2018 and were mostly carried out in Australia, the UK,
and the USA.
Examined interventions ranged across clinical, school‐based,
or home‐based settings, with group or individual treatment for-
mats. Twenty‐two of the studies used a CBT intervention. One
study used peer‐mediated theater therapy and one study
examined the benefits of Thai traditional massage for reducing
anxiety. Most interventions involved parents/caregivers and
were conducted face‐to‐face.
1.2 | What are the main findings of this review?
Overall, the effects of interventions on anxiety show a statistically
significant moderate to high effect, compared to waitlist and
treatment‐as‐usual control conditions at posttreatment.
However, effects differ depending on who reports on the stu-
dent's anxiety. Clinician reports indicate a very high statistically
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significant effect, parent reports indicate a high significant effect, and
self‐reports indicate only a moderate significant effect on the
reduction of anxiety in students with ASD.
There are larger effects for treatments that involve parents than
for student‐only interventions. Effects are also larger for individual
one‐on‐one interventions compared to treatments delivered in a
group with peers.
There are several risk‐of‐bias issues in most studies included in
the review, mainly due to the unavoidable limitation that participants
cannot be blinded to the treatment group, which may upwardly bias
the estimated effects.
There are also limitations in the description of randomization
in a third of the studies, so findings should be treated with
caution.
1.3 | What do the findings of this review mean?
The findings provide evidence in support of interventions, particu-
larly CBTs, designed to reduce anxiety symptoms in school‐aged
children with ASD.
These findings accord with and build upon the findings of pre-
vious systematic reviews into the effectiveness of interventions to
reduce anxiety in children and youth with ASD. However, because of
the risk of bias in current findings, it would be useful to have further
studies with larger sample sizes and to reduce potential biases where
possible.
1.4 | How up‐to‐date is this review?
The review authors searched for studies up to the end of 2018.
2 | EXECUTIVE SUMMARY/ABSTRACT
2.1 | Background
Anxiety is a common problem in school‐aged children with
ASD. CBT and other psychosocial interventions have been de-
veloped as alternatives to pharmacological intervention to treat
anxiety symptoms in students with ASD without co‐occurring
intellectual disability. This present synthesis of evidence is a
systematic review and meta‐analysis examining the efficacy of
interventions for reducing anxiety among school‐aged children
with ASD.
2.2 | Objectives
This review aims to address the question of what the relative ef-
fectiveness of interventions is for managing anxiety of school‐aged
children with ASD in school, family, and clinical settings.
2.3 | Search methods
The following databases were searched for references from 1996 up to
31 December 2018: EBSCO (including Academic Search Complete,
British Education Index, CINHAHL, Education Research Complete, ERIC,
PsychINFO, and SocINDEX), Informit (A +Education), Elsevier (including
EMBASE and SCOPUS), PubMed and Proquest (CBCA Complete). We
also searched the reference lists of published and unpublished literature
papers, as well as gray literature sources, selected websites, trial re-
gistries, and experts in the field of autism to inquire about studies.
2.4 | Selection criteria
Studies were included in the review if they met the following criteria.
1. The patient/client population was school‐aged children (5 to 18 years
old) diagnosed with ASD (inclusive of autism, ASD, Autistic Disorder,
Asperger's Disorder, Asperger Syndrome, atypical autism, and PDD‐
NOS) by a professional eligible to diagnose these conditions, and also
experiencing anxiety symptoms or a diagnosis of an anxiety disorder
provided by a professional eligible to diagnose such conditions.
2. The intervention was focused on reducing anxiety symptoms and
included at least one of the following seven elements: (a) psy-
choeducation, (b) exposure, (c) cognitive restructuring, (d) parent
training or parent psychoeducation, (e) relaxation, (f) modeling,
and (g) self‐monitoring.
3. At least one outcome measure was a standardized continuous
measure of anxiety (parent, clinician or self‐reported).
4. The study was published between the years 1996 and 2018.
2.5 | Data collection and analysis
Four authors independently selected and appraised studies for in-
clusion, while two authors evaluated the risk of bias in each subse-
quently included study. All outcome data were continuous, from
which standardized mean difference effect sizes were calculated. We
conducted random effects meta‐analysis, which means we assumed
individual studies would provide different estimates of treatment
effects. Where outlier studies were identified, analyses were re-
peated after the outlier had been removed from the list of studies.
Analyses were conducted separately according to the respondent on
the outcome measure of anxiety: clinician, parent or subject (child or
youth). Moderator analyses were undertaken to examine differences
in effect sizes depending on whether or not the family was involved
and whether treatment occurred in groups or individually.
2.6 | Results
Eighteen randomized controlled trials (RCTs) and six quasi‐experimental
studies met the inclusion criteria. These studies evaluated the effects of
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interventions targeting anxiety in 931 (764 male and 167 females) par-
ticipants aged 3–19 years. Overall, the effects of interventions on anxiety
were statistically significant and of moderate to high effectiveness,
compared to waitlist and treatment‐as‐usual control conditions at post-
treatment (standardized mean difference after removal of outliers
SMD=−0.71, 95% confidence interval [CI]: −0.97, −0.46; z=−5.42,
p< .01), where SMDs of 0.05, 0.19, 0.45, and 0.70 were taken to be
indicative of low, moderate, high, and very high effects, respectively.
Results also suggested the reported effectiveness of treatment varied as
a function of the informant on outcome measures—clinician reports in-
dicate a very high statistically significant effect (SMD=−0.84, 95% CI:
−1.15, −0.54; z=−5.43, p< .01), while parent reports indicate a high
significant effect (SMD=−0.53, 95% CI: −0.76, −0.31; z=−4.73, p< .01).
Results based on the subjects’ self‐reports indicated a moderate sig-
nificant effect on the reduction of anxiety (SMD=−0.35, 95% CI: −0.55,
−0.15; z=−3.41, p= .001).
Moderators indicated larger effects for treatments that in-
volved parents (SMD = −0.74, 95% CI −1.06, −0.42; z = −4.55,
p < .01) than for student‐only interventions (SMD = −0.60, 95% CI
−1.03, −0.17; z = −2.73, p < .01). Treatments that were adminis-
tered individually one‐on‐one (SMD = −1.24, 95% CI −1.75, −0.74;
z = −4.87, p < .01), indicated larger effects than for treatments
delivered in a group context with peers (SMD = −0.37, 95% CI
−0.54, −0.19; z = −4.10, p < .01).
No adverse events were reported. Given the nature of the inter-
ventions and the selected outcome measures, the risk of performance
and detection bias are generally high, particularly for those studies that
used outcome measures based on parent and self‐reports.
2.7 | Authors’ conclusions
There is evidence that CBT is an effective behavioral treatment for
anxiety in some children and youth with ASD without co‐occurring in-
tellectual disability. Evidence for other psychoeducational interventions
is more limited, not just due to the popularity of CBT but also due to the
quality of the smaller number of non‐CBT studies available.
While there is evidence that CBT is an effective behavioral
treatment for anxiety in some children and youth with ASD, work
remains to be done in terms of identifying the characteristics of these
interventions that contribute to their effectiveness and identifying
the characteristics of participants who are more likely to respond to
such interventions.
3 | BACKGROUND
3.1 | The condition
ASD refers to a group of neurodevelopmental disorders character-
ized by difficulty with communication and social interaction, and the
presence of restricted, rigid, and routinized patterns of behaviors and
interests (American Psychiatric Association, 2013). These symptoms
appear on a continuum (or spectrum), with some children experien-
cing relatively mild symptoms, while others experience quite severe
symptomatology. Notwithstanding the changing ways in diagnosing
children with ASD, the reported prevalence appears to be increasing
over time (ABS, 2016; Fombonne, 2018). For example, the current
rate of prevalence in the United States (US) has reportedly risen by
15% over recent years to 1 in 59 (Autism Speaks, 2016; Baio
et al., 2018; CDC, 2012), while in Australia, the rate has increased by
42% between 2012 and 2016, to 1 in 150 children (ABS, 2016).
In addition to increasing numbers, recent research shows that
the number of students with ASD attending mainstream schools is
also increasing (Zainal & Magiati, 2016). The exact reason for the
increase in prevalence is unclear, but may be related to changes in
the Diagnostic and Statistical Manual of Mental Disorders (DSM;
American Psychiatric Association, 2013; Fombonne, 2018), as well as
increased awareness and better recognition of borderline cases that
were otherwise previously diagnosed as anxiety, bipolar, or other
related disorders.
3.2 | Anxiety in ASDs
Anxiety is characterized by fear. Symptoms can include somatic
complaints, such as stomach ache, headache, sleeplessness, and
diarrhea, as well as other symptoms including tiredness, irritability,
and difficulty concentrating (Beyondblue, 2017). Some level of anxi-
ety is normal. However, when the fear is persistent, excessive and
interferes with one's ability to function normally, a diagnosis of an
anxiety condition may be warranted.
Anxiety symptoms have been noted in individuals with ASD since
the disorder was first described more than 70 years ago (Lyons &
Fitzgerald, 2007; Uljarević, Nuske, & Vivanti, 2016). Recent research
continues to show that those with ASD exhibit significantly higher
rates of anxiety symptoms when compared to typically developing
individuals (Bellini, 2004; Gadow, Devincent, Pomeroy, & Azizian,
2005; Lopata et al., 2010). Higher rates of anxiety in ASD populations
compared to populations with other disorders, including Down's
Syndrome, Williams Syndrome, and Conduct Disorder, have also
been noted (Evans, Canavera, Kleinpeter, Maccubbin, & Taga, 2005;
Green, Gilchrist, Burton, & Cox, 2000; Rodgers, Riby, Janes, Connolly,
& McConachie, 2012).
Although the reported rate of anxiety for those with ASD varies
widely (e.g., from 13% to 84%), the majority of studies suggest that a
realistic estimate is between 40% and 50% (van Steensel, Bögels, &
Perrin, 2011).
The majority of studies undertaken exploring anxiety and ASD
have focused on very young children, or older adolescents and adults.
Fewer studies have been undertaken with school‐aged children, but
those studies that have been conducted suggest a high co‐occurrence
of anxiety in ASD populations of this age group (Ashburner, Ziviani, &
Rodger, 2010; Gjevik, Eldevik, Fjæran‐Granum, & Sponheim, 2011;
Lecavalier, 2006). The prevalence of anxiety among school‐aged
children is of particular concern considering that anxiety during this
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period has a negative impact on intellectual functioning and academic
achievement, and broadly on a child's overall school‐functioning
(Mazzone et al., 2007; Wood, 2006). School may present students
with ASD particular cognitive, social and behavioral challenges that
may increase levels of anxiety, and conversely, increased anxiety can
impair school‐functioning. In addition, teachers tend to perceive
students with ASD as having more difficulty with academic success
and with anxiety than their typically developing peers (Ashburner
et al., 2010). Additional studies of children with an ASD have shown
that anxiety negatively impacts a child's ability to participate in
home, school, and community settings, and effects child and family
well‐being and quality of life above and beyond the core symptoms of
ASD (Davis, White, & Ollendick, 2014; Pellecchia et al., 2016).
Anxiety also has long term impacts. If left untreated, anxiety persists
into adulthood and can progress into other disorders, such as
depression (Seligman & Ollendick, 1998; US Public Health
Service, 2000). Moreover, chronic anxiety is related to reduced em-
ployment opportunities and social networks, and thus is associated
with the societal and economic burden (Davis, Ollendick, & Nebel‐
Schwalm, 2008; Velting, Setzer, & Albano, 2004).
While it may sometimes be difficult to distinguish between the
characteristics of ASD and the characteristics of anxiety, this review
assumes that a change in anxiety levels as indicated by changes in
standardized and validated measures of anxiety while the diagnosis
of ASD remains can be taken as an indicator of a treatment effect on
anxiety.
3.3 | The intervention
Interventions and programs that aim to address anxiety and the
challenges that school‐aged children with ASD face in educational
environments, may improve their overall school‐functioning and later
life outcomes. Against this background, the need for accurate treat-
ment of anxiety in school‐aged children with ASD is evident. There
are numerous interventions currently available for the treatment of
anxiety in children and young people.
The focus of this review is on interventions designed to help a
child's functioning in real‐world settings such as school and the home,
although treatment or interventions may be located in a range of
settings, including schools, the home, online, and research and sup-
port centers. Thus, studies assessing only the impact of pharmaco-
logical interventions were excluded, while a study investigating the
impact of CBT on academic performance would be included. Re-
search indicates CBT is useful for treating anxiety disorders, but less
is known about its efficacy in treating anxiety within ASD populations
(Nadeau et al., 2011).
3.4 | How the intervention might work
Rotheram‐Borus, Swendeman, and Chorpita (2012) proposed that all
existing interventions for anxiety incorporate one or more of the
following seven elements: (a) psychoeducation, (b) exposure, (c)
cognitive restructuring, (d) parent training or parent psychoeduca-
tion, (e) relaxation, (f) modeling, and (g) self‐monitoring.
CBT is a relatively popular alternative to pharmacological in-
tervention for anxiety symptoms that incorporates a number of
these elements. At its core, CBT involves, as the name suggests,
cognitions or thoughts and how these may contribute to or alle-
viate anxiety, and behavior or how a person might behave or re-
spond to a situation or experience that may trigger anxiety, as well
as how these cognitions and behavior interact. A CBT‐based in-
tervention for young people with ASD and anxiety will probably
include educational sessions for the young people, and possibly
their parents, about negative thought patterns and cognitive dis-
tortions such as “catastrophising” and how these contribute to
anxiety (psychoeducation and parent psychoeducation/training)
and how to challenge these thought patterns (cognitive re-
structuring). These sessions might also be combined with other
types of intervention like supported exposure to situations that
the young people have previously found anxiety‐provoking, such
as social interactions, with coaching sessions on how to monitor
their thoughts, and to recognize and control physical reactions to
stress and anxiety (self‐monitoring and relaxation).
Previous research has indicated that CBT can be effective and ef-
ficient in treating anxiety in children and youth as well as adult popu-
lations (Kaczkurkin & Foa, 2015; Kendall & Southam‐Gerow, 1996;
Otte, 2011), but the core features of ASDs must be considered when
determining whether and how the treatment might be appropriate for
use with ASD populations. Some characteristics of CBT, such as its
highly‐structured, pragmatic focus on current problems may align with
features of ASD such as increased need for structure and order, while
other aspects such as reliance on verbal communication with the
therapist, insight in one's own thoughts, feeling and actions, and re-
cognition of emotions in oneself and others, may prove challenging for
some clients with ASD. For these reasons, many CBT‐based treatments
for anxiety have been modified specifically for use with ASD popula-
tions, including such considerations as replacing group sessions with
one‐on‐one treatments sessions, increasing the amount of time dedi-
cated to engagement with the therapist, increasing the number of
sessions dedicated to emotion recognition training, adapting activities,
and worksheets to the specific strengths and weaknesses of the clients
or incorporating clients’ special interests into treatment where appro-
priate (NICE, 2013).
3.5 | Why it is important to do the review
Since children spend a significant portion of their day at school,
teachers and clinicians working in the education sector have sig-
nificant responsibility for recognizing signs of ASD and anxiety, and
in implementing interventions and supports that are evidence‐based
and tailored to the needs of the child. Further, decision making re-
garding treatment should be informed by the latest evidence
available.
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A preliminary search of PROSPERO, MEDLINE, the Cochrane Da-
tabase of Systematic Reviews (apart from this copublished protocol), and
the JBI Database of Systematic Reviews and Implementation Reports
was conducted and no current or underway systematic reviews on the
topic were identified. A number of reviews on various aspects of anxiety
in ASD published in the last 10 years were found. These reviews covered
phenomenology and prevalence of anxiety (MacNeil, Lopes, & Minnes,
2009; van Steensel et al., 2011;White, Oswald, Ollendick, & Scahill, 2009;
Wigham & McConachie, 2014), assessment (Lecavalier et al., 2014;
Wigham & McConachie, 2014), and treatment (Johnco & Storch, 2015;
Kreslins, Robertson, & Melville, 2015; Sukhodolsky, Bloch, Panza, &
Reichow, 2013; Ung, Selles, Small, & Storch, 2015; Vasa et al., 2016).
However, none of the reviews published thus far have: (a) focused
specifically on school‐aged children with ASD; (b) covered the
range of available treatments, but instead focused only on specific
treatments, such as, for example, CBT or psychosocial treatments;
(c) explored mediators and moderators of treatment outcomes;
and (d) provided practical guidance for education professionals
and parents to enable increased use of evidence‐based treatments
in their everyday practice.
Accordingly, this review aimed to synthesize evidence about in-
terventions to reduce anxiety symptoms in school‐aged children with
ASD. While clinical studies were not excluded per se, this review
sought to move beyond interventions that were relevant only for
clinical practice and care in clinical settings, and prioritized studies
that drew out implications for school‐aged children that would help
their functioning in real‐world settings such as school and the home.
To achieve this aim, the review employed a quantitative (experi-
mental and quasi‐experimental) approach, in order to establish evi-
dence of impact (Joanna Briggs Institute, 2014).
4 | OBJECTIVES
4.1 | The problem
The sheer volume of published research, and the different aims, foci,
and methodology of those studies, makes evidence‐based practice
difficult for professionals, including for those working in the educa-
tion sector. The current review contributes to providing consolidated
sources of information for professionals. Results of the review are
intended to inform professionals working in the education sector and
parents, but may also inform policymakers in this sector.
Hence, this review aimed to address the following research question.
1. What is the relative effectiveness of interventions for managing
anxiety of school‐aged children with ASD that have been used in
school, family, and clinical settings?
In the process, this review also identified the following:
• The interventions used for managing anxiety of school‐aged
children with ASD in school, family, and clinical settings.
• The evidence‐based practices that school staff, parents, and other
professionals can employ to mitigate anxiety‐related symptoms in
school‐aged children with ASD.
5 | METHODS
5.1 | Criteria for considering studies for this review
5.1.1 | Types of studies
While the original strategy did not set limits on the types of studies
to be reviewed, the results of initial searching proved so prolific that
it was decided, on the basis of quality, to focus on two main types of
quantitative studies—RCTs and quasi‐experimental studies (in which
a control group was employed but allocation was not strictly ran-
domized). The mixed methods strategy proposed initially in the
protocol (Lietz et al., 2018) was thus replaced with a purely quanti-
tative review and meta‐analysis. Otherwise, this review followed the
approaches to search strategies and analyses specified in the study
protocol (Lietz et al., 2018) which was published by the Campbell
Collaboration prior to starting the research.
The studies could occur in schools or out‐of‐school settings (e.g.,
home, larger community) or clinical settings, as long as the inter-
vention was designed to improve outcomes in real‐world settings.
The comparison groups used in the majority of included studies
were waitlist control groups or standard treatment/treatment‐as‐
usual (TAU) groups. Two studies, namely vanSteensel_20151 and
Ohan_2016, were included as pre‐ and posttest comparisons only. In
vanSteensel_2015, the intended comparison group was children with
an anxiety disorder but no ASD. Ohan_2016 combined their
immediate treatment and waitlist groups after initial testing
indicated that there was no significant change in the scores of the
waitlist group, thereafter reporting pretreatment and posttreatment
scores for the combined group. A third study, Pryor_2016, used a
crossover design so only results collected after the first intervention
round were used in the current analyses.
5.1.2 | Types of participants
The target population for the review is mainstream school‐aged
children, diagnosed with ASD (inclusive of autism, ASD, Autistic
Disorder, Asperger's Disorder, Asperger Syndrome, atypical autism,
PDD‐NOS) by a professional eligible to diagnose these conditions,
and also experiencing anxiety symptoms or a diagnosis of an anxiety
disorder provided by a professional eligible to diagnose such condi-
tions. The majority of included studies (21 of 24) used a screening
instrument to confirm the existence of clinically significant levels of
1Studies included in this review are cited by using first‐author_date, rather than APA style.
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anxiety at intake, while the remaining studies relied on parent or
teacher reports of elevated anxiety.
If studies included a sample of children in the target population as
well as other children (e.g., the general population) and the findings
were separated for the ASD subgroup, the study was included in the
review whereby the type of ASD diagnosed did not matter. In contrast,
if the study findings were not reported separately (e.g., the results for
children with ASD and ADHD were combined for analysis), the study
was excluded from the review as the impact of the intervention on
only the ASD sample would be impossible to isolate.
To be included in the review, either all participants in a study had
to be of mainstream school age or a majority of participants had to be
of mainstream school age. This meant that while most studies involved
young people aged 6–16 years, one study (Piravej_2009) included
some younger children (minimum 3 years old) and six studies included
slightly older participants (MacKinnon_2014, Pryor_2016,
White_2013: max. 17 years; Murphy_2017, van Steensel_2015: max.
18 years; and Hepburn_2019: max. 19 years). No restrictions were
imposed in terms of background variables such as socioeconomic
status, or profiles of children with ASD with respect to characteristics
such as level of cognitive functioning or ASD severity/classification, for
example. However, given the types of interventions that were included
and the requirement in some studies for the participating children and
adolescents to report on their posttreatment anxiety levels, the ma-
jority of studies did include some requirements for minimum IQ or at
least verbal IQ (VIQ) (generally a full scale or VIQ of 70), and beha-
vioral standards (e.g., exclusion of violent subjects).
5.1.3 | Types of interventions
This review included all treatments for anxiety where the large ma-
jority of participants were of mainstream school age, with ASD which
occurred in schools, families or in clinical settings and that en-
compassed at least one of the elements outlined by Rotheram‐Borus
et al. (2012). As such, studies that focused solely on pharmacological
interventions (e.g., selective serotonin reuptake inhibitors) were ex-
cluded from the review. Given the focus on psychoeducation and
cognitive restructuring in Rotheram‐Borus et al.'s (2012) re-
commendations, many of the included studies used a form of CBT.
Those that did not examine CBT encompassed elements of relaxa-
tion, modeling, and self‐monitoring.
Two examples of included studies identified by the initial search
criteria are provided for illustrative purposes.
Chalfant, A. M., Rapee, R., & Carroll, L. (2006). Treating anxiety
disorders in children with high functioning autism spectrum dis-
orders: A controlled trial. Journal of Autism and Developmental Dis-
orders, 37 (10), 1842‐1857.
A family‐based, cognitive behavioral treatment for anxiety
in 47 children with comorbid anxiety disorders and High
Functioning Autism Spectrum Disorder (HFA) was
evaluated. Treatment involved 12 weekly group sessions
and was compared with a waiting list condition. Changes
between pre‐ and post‐treatment were examined using
clinical interviews as well as child‐, parent‐ and teacher‐
report measures. Following treatment, 71.4% of the
treated participants no longer fulfilled diagnostic criteria
for an anxiety disorder. Comparisons between the two
conditions indicated significant reductions in anxiety
symptoms as measured by self‐report, parent report and
teacher report. Discussion focuses on the implications for
the use of cognitive behavior therapy with HFA children,
for theory of mind research and for further research on the
treatment components.
Wood, J. J., Drahota, A., Sze, K., Har, K., Chiu, A., & Langer, D. A.
(2009). Cognitive behavioral therapy for anxiety in children with
autism spectrum disorders: A randomized, controlled trial. The Jour-
nal of Child Psychology and Psychiatry, 50 (3), 224–234.
Background: Children with autism spectrum disorders of-
ten present with comorbid anxiety disorders that cause
significant functional impairment. This study tested a
modular cognitive behavioral therapy (CBT) program for
children with this profile. A standard CBT program was
augmented with multiple treatment components designed
to accommodate or remediate the social and adaptive skill
deficits of children with ASD that could pose barriers to
anxiety reduction. Method: Forty children (7‐11 years old)
were randomly assigned to 16 sessions of CBT or a 3‐
month waitlist (36 completed treatment or waitlist).
Therapists worked with individual families. The CBT
model emphasized behavioral experimentation, parent‐
training, and school consultation. Independent evaluators
blind to treatment condition conducted structured diag-
nostic interviews and parents and children completed
anxiety symptom checklists at baseline and posttreat-
ment/postwaitlist. Results: In intent‐to‐treat analyses,
78.5% of the CBT group met Clinical Global Impressions‐
Improvement scale criteria for positive treatment response
at posttreatment, as compared to only 8.7% of the waitlist
group. CBT also outperformed the waitlist on diagnostic
outcomes and parent reports of child anxiety, but not
children's self‐reports. Treatment gains were maintained
at 3‐month follow‐up. Conclusions: The CBT manual em-
ployed in this study is one of the first adaptations of an
evidence‐based treatment for children with autism spec-
trum disorders. Remission of anxiety disorders appears to
be an achievable goal among high‐functioning children
with autism.
The following is an example of study that was excluded due to it
being a pharmacological only treatment:
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Couturier, J., & Nicolson, R. (2002). A retrospective assessment
of citalopram in children and adolescents with pervasive develop-
mental disorders. Journal of Child and Adolescent Psychopharmacology,
12(3), 243–248.
Although selective serotonin reuptake inhibitors have been
used to treat symptoms of aggression and anxiety in chil-
dren and adolescents with pervasive developmental dis-
orders (PDDs), there are no published reports of the use of
citalopram in this population. The purpose of this study was
to examine the benefits and adverse effects of citalopram in
a group of children and adolescents with PDDs. Target
behaviors included aggression, anxiety, stereotypies, and
preoccupations. Seventeen patients with PDDs (14 with
autistic disorder, three with Asperger's disorder) (mean
age = 9.4 ± 2.9 years; range 4‐15 years) were treated with
citalopram for at least 2 months (mean duration of treat-
ment = 7.4 ± 5.3 months; range 1‐15 months). Treatment
was initiated at a low dose (5mg daily) and was increased
by 5mg weekly as tolerated and as necessary. The mean
final dose was 19.7 ± 7.8mg (range 5‐40mg). Outcome
was based on a consensus between clinician and parents,
using the Improvement item of the Clinical Global Im-
pressions Scale as a guide. Ten (59%) children were judged
to be much improved or very much improved regarding
target behaviors. Core symptoms of PDDs (social interac-
tions, communication) did not show clinically significant
improvement. Citalopram was generally well tolerated, al-
though four patients developed treatment‐limiting adverse
effects: two with increased agitation, one with insomnia,
and one with possible tics. The results of this case series
suggest that citalopram has beneficial effects on some in-
terfering behaviors associated with PDDs with few adverse
effects. Controlled trials are warranted.
Other excluded studies are summarized in Table 1.
5.1.4 | Types of outcome measures
The primary outcome for included studies was anxiety, thus studies
that focused on social skills interventions or other symptomatology
of ASD as primary outcomes were excluded from this review. The
measurement of anxiety (and related terms) had to be undertaken
using valid and reliable approaches such as diagnostic interviews,
screening instruments, observational ratings, and behavioral
checklists—irrespective of the informant (e.g., student, parent,
teacher).
Only the immediate posttreatment outcome is included in the
current review, as the variety of follow‐up schedules in the studies
proved quite large, with 10 studies having no follow‐up, 6 studies
following‐up less than 3 months after the end of the intervention,
4 studies after exactly 3 months, and 4 studies more than 3 months
after the intervention (see Table 2). Compiling the results from
different studies into ranges may have resulted in a loss of data
integrity.
5.1.5 | Types of settings
The settings in which the intervention was applied were real‐
world settings such as school or home. While 19 of the inter-
ventions were conducted in a clinical setting (either a university‐
based clinic or a community clinic, such as Child and Adolescent
Mental Health), the intention of the studies was to address issues
that were pertinent to the subjects’ lives—either at home or in
school.
5.2 | Search methods used for the identification of
studies
Our search strategy identified published as well as unpublished lit-
erature, first, via electronically searching 12 bibliographic databases
and, second, by searching additional gray literature sources such as
selected websites, repositories, and research registers. We also
manually searched targeted journals and reference lists and con-
tacted key researchers in the field of autism to inquire about studies.
To ensure our search was as extensive as possible, we balanced our
search strategy as far as was practical, toward a sensitive search
rather than a precise search.
In summary, studies were included in the review if they met the
following criteria:
TABLE 1 Characteristics of studies excluded at abstract screening stage
Author and
Publication Date Title Reason for exclusion
Schohl et al. (2014) A replication and extension of the PEERS intervention: Examining effects on
social skills and social anxiety in adolescents with autism spectrum disorders.
Different intervention focus, no anxiety
diagnosis or measurement at intake
Ooi et al. (2008) Effects of cognitive‐behavioral therapy on anxiety for children with high‐
functioning autistic spectrum disorders.




An open trial of cognitive behavioral therapy for anxiety disorders in early
adolescents with autism spectrum disorders.
Observational study (no control group)
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1. All or the large majority of the patient/client population were
mainstream school‐aged young people diagnosed with ASD (in-
clusive of autism, ASD, Autistic Disorder, Asperger's Disorder,
Asperger Syndrome, atypical autism, and PDD‐NOS) by a pro-
fessional eligible to diagnose these conditions, and also experi-
encing anxiety symptoms or a diagnosis of an anxiety disorder
provided by a professional eligible to diagnose such conditions;
2. The intervention was focused on reducing anxiety symptoms
and included at least one of the following seven elements: (a)
psychoeducation, (b) exposure, (c) cognitive restructuring, (d)
parent training or parent psychoeducation, (e) relaxation, (f)
modeling, and (g) self‐monitoring.
3. At least one outcome measure was a standardized continuous
measure of anxiety (parent, clinician, or self‐reported).
4. The study was published between the years 1996 and 2018.
5.2.1 | Electronic searches
A broad range of bibliographic databases were electronically
searched for studies that matched our inclusion criteria:
• Academic Search Complete (via EBSCO)
• A+ Education (via Informit)
• British Education Index (via EBSCO)
• CBCA Complete (via Proquest)
• CINAHL (via EBSCO)
• Education Research Complete (via EBSCO)
• EMBASE (via Elsevier)
• ERIC (via EBSCO)
• PsycINFO (EBSCO)
• PubMed
• SCOPUS (via Elsevier)
• SocINDEX (via EBSCO)
Our general search statement, set out below, was customized
to fit the available search features of the bibliographic databases
(see Appendix A in the Supporting Information Material for the
customized statements). In this general search statement, the *
symbol was used to indicate where our search covered variations
in the root of the word.
(ASD OR Asperger* OR autis* OR Pervasive Develop-
mental Disorder OR PDD NOS OR PDD unspecified)
AND (Anxiety OR anxious OR internali* OR fear)
AND (Student OR child* OR adolescen* OR pre-
adolescen* OR pre adolescen* OR youth OR teen*
OR teen age* OR young people OR young person OR
boy OR girl) AND (Intervention OR treatment
OR therap* OR psychotherap* OR evaluation OR
outcome OR program OR trial* OR experimental
OR control group OR random* OR best practi* or
evidence based)
5.2.2 | Searching other resources
Other resources that were search included gray literature, theses, con-
ference proceedings, research reviews, purposely selected websites, re-
ference lists from previously identified articles, and by contacting
researchers and colleagues in the field and from the review's advisory
group.
Google was used to identify gray literature from websites in the
government, organization, and education domains (site:gov, site:edu,
site:org). References were checked up to the first 200 results. The
following search statement was used within the limits of the three
specified domains was:
(autism OR autistic OR ASD OR asperger OR "PDD
NOS" OR "PDD unspecified" OR "pervasive develop-
mental") AND (anxiety OR anxious) AND (student OR
child OR children OR adolescent OR youth OR teen OR
boy OR girl) AND (intervention OR treatment OR ther-
apy OR psychotherapy)‐pubmed filetype:pdf
OpenGrey (European) was used to identify relevant European
gray literature. The search statement was:
(asd OR Asperger* OR autis* OR Pervasive Developmental
Disorder* OR PDD NOSOR PDD unspecified) AND (Anxiety
OR anxious OR internali* OR fear) AND (Student OR child*
OR adolescen* OR preadolescen* OR pre adolescen* OR
youth OR teen* OR teenage* OR young people OR young
person OR boy OR girl)
Institutional repositories: We searched the “Contents” of the Direc-
tory of Open Access Repositories (OpenDOAR) to identify research
papers from institutional repositories. Our general search statement
was customized to fit with the available search fields in the OpenDOAR
Google Custom Search. Our search statement was:
(autism OR asd OR asperger OR "PDD NOS" OR "PDD
unspecified" OR "pervasive developmental") AND (anxiety
OR anxious) AND (student OR child OR children OR ado-
lescent OR youth OR teen OR boy OR girl) AND (inter-
vention OR treatment OR therapy OR psychotherapy) ‐
pubmed –ncbi
Theses: For Networked Digital Library of Theses and Disserta-
tions, a customized search strategy was used and the search limited
by available population tags:
(asperger* OR autistic OR autism OR asd) AND (anxiety
OR anxious) AND (treatment* OR intervention* OR
therapy OR psychotherapy)
For WorldCat, a customized search strategy was used and the
search limited by
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Thesis/dissertation:
(Asperger* OR autistic OR autism OR asd) AND (anxiety
OR anxious) AND (intervention* OR treatment* OR
therap* OR psychotherapy*)
For American Doctoral Dissertations (EBSCO), the search
statement was:
(Asperger* OR autism OR autistic OR ASD OR PDD OR
"Pervasive Developmental") AND (anxiety OR anxious
OR fear OR internal*)
Conference proceedings: In addition to conference proceedings
and papers indexed in our selected databases, we identified con-
ference literature via a search on SCOPUS which is a multi-
disciplinary database. This search was limited to conference papers in
the collections other than the Social Sciences, Humanities, or Neu-
roscience as these collections were covered elsewhere. The search
statement was:
TITLE‐ABS‐KEY((asperger* OR autis* OR asd OR "Per-
vasive Developmental" W/0 disorder* OR "PDD NOS" OR
"PDD unspecified")) AND TITLE‐ABS‐KEY((anxiety OR
anxious OR internali* OR fear)) AND TITLE‐ABS‐KEY
((student OR child* OR adolescen* OR preadolescen* OR
(pre W/0 adolescen*) OR youth OR teen* OR (teen W/0
age*) OR "young people" OR "young person" OR boy OR
girl)) AND TITLE‐ABS‐KEY((intervention OR treatment
OR therap* OR psychotherap* OR evaluation OR out-
come OR program* OR trial* OR experimental OR (con-
trol W/0 group) OR random* OR (best W/0 practi*) OR
"evidence
based")))
Research reviews: Wherever possible, the following search
statement was executed in the list of resources below:
(asperger OR autism OR autistic OR ASD OR "pervasive devel-
opmental" OR "PDD NOS")
• Campbell Library
• Cochrane Central Register of Controlled Trials (CENTRAL)
• The JBI Database of Systematic Reviews and Implementation
Reports.
• Database of Promoting Health Effectiveness Reviews (DoPHER)
• Evidence for Policy and Practice Information and Coordinating
Centre (EPPI‐Centre)
• Cochrane Database of Systematic Reviews
• PROSPERO International prospective register of systematic
reviews
Where further refinement was necessary, we added additional
search terms relating to the concept of anxiety.
Targeted searches of selected websites: We explored the websites
of selected agencies, research centers and professional associations
including the following:
• Agency for Healthcare Research and Quality
• The Association for Science in Autism
• Australasian Society for Autism Research





• Autism Program at Yale University
• Autism Research Centre—Cambridge University
• Autism Research Centre
• Autism Research Institute
• Autism Research, Policy, Practice
• Autism Research Trust
• Autism Science Foundation
• Autism Speaks
• Autism Intervention Research Network on Physical Health
(AIR‐P)
• Autism Society
• Autism Spectrum Australia (Aspect)
• Autistica
• The Cambridge Autism Research Centre
• Center for Autism Research Excellence (CARE) Boston University
• Center for Autism Research
• Center for Autism Research and Treatment (CART)
• Centers for Disease Control and Prevention – Autism Spectrum
Disorder
• Center for Excellence in Autism Research at the University of
Pittsburgh
• Child Study Center—Yale School of Medicine
• Global Research in Autism and Neurodevelopment
• Interactive Autism Network
• International Society for Autism Research
• Kennedy Krieger Institute: Autism Spectrum Disorders Research
• Medline Plus Healthline
• National Autism Center
• The National Autistic Society
• National Institute of Health Care Excellence (NICE)
• National Institute of Mental Health
• National Institutes of Health (NIH)
• National Database for Autism Research
• New York Academy of Medicine (NYAM) Gray Literature
Report
• Olga Tennison Autism Research Centre, La Trobe University
• Research Autism
• Scottish Autism Research Group
• Simons Foundation Autism Research Initiative
• Vanderbilt Evidence‐based Practice Center
• World Health Organization—Digital Library
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Reference lists: We searched the reference lists of previously
published reviews and meta‐analyses that we identified as well as
the reference lists of each of the studies identified for our
analysis.
Current literature: After our initial search, we set up alerts in
Google Scholar and, where possible, in the bibliographic data-
bases, in order to identify any new literature within the time of
our study. New table of content alerts were also set up for key
journal titles including Research in Autism Spectrum Disorders,
Autism, and the Journal of Autism and Developmental Disorders.
Alerts were manually scanned for any new references that fitted
our search criteria.
Colleagues: Contact was also made with researchers and collea-
gues in the field and from the review's advisory group, to identify any
additional studies, particularly those that might have been ongoing or
unpublished at the time of our work.
Ongoing trials: We identified current and ongoing trials via the
following trial registries:
• International Clinical Trials Registry Platform Search Portal
• Clinical Trials.Gov
• Trials Register of Promoting Health Interventions (TRoPHI)
• Cochrane Central Register of Controlled Trials ‐ Cochrane Library
We searched for the following terms:
(Asperger OR autism OR autistic OR asd OR "perva-
sive developmental" OR "pdd nos")
Where further refinement was required, we included anxiety
and/or trials limited to children.
5.2.3 | Publication date range
Our searches were limited to a publication date range of 1996–2018.
We selected 1996 as the earliest publication date in order to narrow
the scope of interventions to current approaches used in the last 20
years. Given the development of understanding in this field, we be-
lieve that interventions before this date would be less progressive in
their approach. The initial database searches were conducted be-
tween May 4, 2017, and June 7, 2017. Updates of database searches
were conducted via alerts based on the original search statements or
by rerunning search statements, up to December 31, 2018.
5.2.4 | Other criteria
The searches in our selected sources were not restricted by geo-
graphy, language, publication type, or by publication status. However,
the selected sources are focused on the English language in keeping
with our database subscriptions and the primary language of the
authors.
5.3 | Data collection and analysis
5.3.1 | Selection of studies
As a first step in the screening process, four reviewers independently
assessed titles and abstracts of a purposely heterogeneous subset of
five studies identified through the searches. The purpose of this step
was twofold: first, it determined their potential eligibility for inclu-
sion in the review and second it served to develop a common un-
derstanding and application of inclusion criteria. Once a consensus
regarding the application was reached, all abstracts were assessed by
at least two reviewers. Where two reviewers disagreed regarding the
inclusion of an abstract in the study, resolution was sought through
discussion with the full project team. At the end of this step, studies
that clearly did not meet the criteria, as well as duplicates, were
removed.
5.3.2 | Data extraction and management
Full‐text articles were then retrieved for the included abstracts.
Reviews of the full‐text articles were undertaken independently by
two reviewers (K. H. and K. D.). Any discrepancies were resolved
through discussion and, where necessary, further details added to
data definitions which may have been unclear. The checklists used
during this review phase are presented in Appendices B and C in the
Supporting Information Material, along with a summary of the ap-
praisal results for excluded papers.
Once papers were selected for inclusion in the review, data were
independently extracted in duplicate by authors K. D. and K. H. using
the standardized data extraction tools from JBI SUMARI (see Ap-
pendix D in the Supporting Information Material for the quantitative
data extraction form, which was operationalized in a spreadsheet).
Discrepancies were checked and resolved. The data extracted in-
cluded specific details about the interventions, populations, study
methods, and outcomes of significance to the review question and
specific objectives.
5.3.3 | Assessment of risk of bias in included studies
The risk of bias assessment was carried out by authors K. H. and K. D.
The assessment was informed by initial data extraction in JBI SU-
MARI and conducted using the Cochrane Collaboration's guidelines
for assessing risk of bias (Higgins, Altman, & Sterne, 2011). Risk of
bias in the selected studies was rated as high risk (bias that poten-
tially reduces the reliability of the results), or low risk (bias that is
unlikely to alter the results), with an unclear category used in cases in
which there was insufficient information in the published study for
the judgment of bias to be made. As the majority of included studies
were RCTs, the risk of bias assessment focused on methodological
issues pertaining to this form of study—sequence generation, allo-
cation concealment, blinding of participants and personnel, blinding
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of outcome assessment, attrition, selective reporting, and other
sources of bias. As a consequence, the quasi‐experimental studies
that were included in this review received higher ratings of risk of
bias, particularly in terms of selection bias.
5.3.4 | Measures of treatment effect
Only one outcome per respondent group was used in the quantitative
syntheses to avoid double counting. In cases where there was more
than one outcome measure per respondent available, we selected an
outcome based on assessments of validity published in Wigham and
McConachie (2014) and Lecavalier et al. (2014), the frequency of use
across the included studies, and the availability of data appropriate
for the meta‐analyses.
Separate statistical analyses were conducted based on the in-
formant for the outcome measures—namely parent, clinician, and
self/student. While two of the included studies collected anxiety
outcome measures from teachers of the subjects (Chalfant_2007;
Luxford_2017), there were not enough teacher‐informants to con-
duct a separate analysis. In addition, the extent of missing data for
these measures was enough to raise concerns about reliability.
In accordance with the JBI SUMARI meta‐synthesis program the
SMD, reported as Cohen's d, and its 95% CI was used as the summary
estimate of treatment effect size and based on the posttreatment/
wait‐list scores reported in each study. This summary statistic was
selected as all studies included continuous measures and all mea-
sures were in the same direction (i.e., higher scores indicating higher
levels of behavior or impact of symptoms) and thus no adjustments
were required. In addition to Cohen's d—although not available in the
JBI SUMARI program at the time of analyses—Hedges’ g is another
method (i.e., formulae) commonly used for the computation of SMD.
Cohen's d and Hedges’ g differ in that the latter uses the version of
the standard deviation formula which divides by N‐1, whereas the
former divides by N. While, therefore, Hedge's g is often preferred
for reviews involving studies with small sample sizes its use would
not have led to different conclusions having been drawn from the
results of the current review.
5.3.5 | Unit of analysis issues
Some of the included studies deviated from standard treatment
versus control comparisons, in employing crossover designs (Pry-
or_2016), inclusion of more than one treatment group (Sofron-
off_2005) or inclusion of a control group without ASD who also
received treatment (vanSteensal_2015).
For the crossover design, data from the baseline and the end of
the first phase (prior to crossover) were used, effectively treating the
alternative treatment group as a “TAU” control. Sofronoff_2005 in-
cluded two treatment arms, one in which children received CBT on
their own and another in which their parents participated in the
treatment with them. While previous reviews have pooled the results
of these two treatment arms (e.g., Kreslins et al., 2015; Ung
et al., 2015), we elected to include them separately, as they do re-
present two different forms of intervention.
The study design of vanSteensal_2015 was relatively more
complex, compared to other included studies, in that it included two
treatment groups—one with ASD and anxiety disorders, one with
anxiety disorders but no ASD diagnosis—and a wait‐list control
(WLC) subgroup of the ASD group. While the argument could have
been made to exclude this study for a lack of formal diagnosis of ASD
for those participants in the “anxiety disorders only” comparison
group, it was decided to retain the study and focus on the immediate
treatment versus WLC comparison within the ASD group.
5.3.6 | Assessment of heterogeneity
Quantitative data were, where possible, pooled by way of statistical
meta‐analysis. Weighted mean differences and their 95% CIs were
calculated for analysis. Heterogeneity was assessed statistically using
the standard χ2 and also explored using subgroup analyses based on
the different study designs included in this review.
5.3.7 | Assessment of reporting biases
Assessing risk of publication bias was an important task because of
its potential influence on estimates of intervention effects. This re-
view analyzed possible publication bias by implementing the trim‐
and‐fill method (Duval & Tweedie, 2000; Schwarzer, 2007), providing
an initial assessment of whether unpublished data on ASD and an-
xiety interventions (likely to have null results) was evident (Uljarević
& Hamilton, 2013).
5.3.8 | Data synthesis approach
Separate statistical analyses were carried out for clinician‐reported,
parent‐reported, and self‐reported outcome measures of anxiety.
Studies were also coded dichotomously for two possible moderator
variables: (a) family involvement or student‐only and (b) group or
individual format. SMD was chosen as the summary estimate of
treatment effect, appropriate for the continuous outcome measures
that were being analyzed. Often, SMD s of 0.2, 0.5, and 0.8 are taken
to be indicative of small, moderate, and large effects, respectively
(Cohen, 1988). However, heeding concerns by Valentine and Cooper
(2003) and Lipsey et al. (2012) that effect in the field of education are
likely to be small and risk being overlooked if based on Cohen's
interpretation, effect sizes were interpreted in an educational con-
text using the metric developed by Higgins et al. (2013) for the UK
Education Endowment Foundation. Accordingly, SMDs of 0.05, 0.19,
0.45, and 0.70 were taken to be indicative of low, moderate, high, and
very high effects, respectively. Moreover, these can be interpreted,
respectively as, 1 month, 3 months, 6 months, and 9 months
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additional developmental progress. A random effects meta‐analysis
was employed due to the variability in outcome measurement in-
struments and interventions across the included studies.
Using the JBI SUMARI meta‐synthesis program, SMD (Cohen's d)
estimates were calculated based on the posttreatment mean scores
and standard deviations provided in each study. Since the direction of
the scales was the same for all outcome measures, no adjustments of
the scores were required. The statistical significance level was set at
p < .05. Forest plots were used to illustrate results from individual
studies. In the case of multiple treatment arms, such as Sofron-
off_2005, the scores of both intervention groups (ITs) were compared
to the control group score. Similarly, if a study reported more than
one outcome measure for a respondent, then both outcomes have
been reported, rather than presenting an average score as previous
systematic reviews have done (e.g., Kreslins et al., 2015; Lang,
Regester, Lauderdale, Ashbaugh, & Haring, 2010; Perihan et al., 2019;
Sukhodolsky et al., 2013; Ung et al., 2015).
5.3.9 | Sensitivity analysis
Given the diversity of interventions and the potentially small sample
of included studies within each intervention type, it was important to
conduct a sensitivity analysis of the impact of a single study, parti-
cularly if it is an outlier, on the overall observed effect size for in-
terventions in any meta‐analysis. The main sensitivity analysis
conducted, focused on excluding single studies which may have had
an unduly large effect on the results. Results were then compared to
provide an indication of the robustness of the review's findings.
6 | RESULTS
6.1 | Description of studies
6.1.1 | Results of the search
The search of the databases yielded 3,417 records, with an additional
177 records identified through other sources. Removal of duplicates
resulted in a total of 2,337 records, which were screened based on
the title and abstract by three of the authors, with 2,218 records
being excluded.
The remaining 119 full‐text articles and theses were assessed for
eligibility and 94 excluded as not meeting the search criteria. One
further study was subsequently excluded as a reanalysis of data re-
ported in an already included study. A total of 24 studies were thus
included in the quantitative meta‐synthesis. A flow diagram of the
study selection is presented in Figure 1.
6.1.2 | Included studies
Twenty‐four studies examining interventions for anxiety for children and
adolescents with ASD are included in this review, identified by first au-
thor and publication date: Chalfant_2007; Clarke_2017; Con-
aughton_2017; Corbett_2017; Fujii_2013; Hepburn_2016; Luxford_2017;
MacKinnon_2014; McConachie_2014; McNally‐Keehn _2013; Mur-
phy_2017; Ohan_2016; Piravej_2009; Pryor_2016; Reaven_2009; Re-
aven_2012; Sofronoff_2005; Storch_2013; Storch_2015; Sung_2011;
vanSteensel_2015; White_2013; Wood_2009; Wood_2015.
F IGURE 1 PRISMA flow diagram outlining
process of study selection
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6.1.3 | Study location
Five of the studies were conducted in Australia, 12 in the United
States, 4 in the United Kingdom (England), and 1 each in Singapore,
Thailand, and The Netherlands. Twenty of the studies were set in
clinical settings attached to medical or university institutions, while
two were home‐based interventions and two were school‐based.
6.1.4 | Study design
Six of the studies were classified as quasi‐experimental designs, in
that they employed a control or comparison group that was not
randomly assigned, while the remaining 18 studies used a rando-
mized WLC design (with varying degrees of fidelity).
6.1.5 | Participants
A total of 931 (764 male and 167 females) participants most of whom
were of mainstream school age (6–16) were included in these studies
(note that subjects in pre‐post studies only counted once). Six of the
studies included older adolescents (up to 19 years of age) while one
study included children as young as 3 years old. All studies had in-
clusion criteria of a documented diagnosis of ASD (often confirmed
during intake assessments) as well as either a concurrent diagnosis of
an anxiety disorder (again, confirmed during intake) or reports from
parents or educators of significant levels of anxiety.
The majority of the studies (21 of 24) limited participants to
individuals with functioning above a certain level of cognitive ability,
most commonly a full scale or verbal IQ of 70 or above, or in one
case, the ability to read and write (in English) at an 8‐year‐old level as
a minimum. Only three studies did not place restrictions (either ex-
plicitly or de facto by requiring that participants be attending a
mainstream school) on the cognitive functioning of participants
(Hepburn_2016; MacKinnon_2014; Piravej_2009). Further informa-
tion, where available, on the cognitive functioning of participants in
each study, is presented in Table 2.
6.1.6 | Interventions
Twenty‐two of the studies used a CBT intervention, with some devel-
oped specifically for use with participants with ASD (e.g., Exploring
Feelings; BIACA and MASSI). Of these, 15 studies involved interven-
tions that included parental involvement (Chalfant_2007; Fuji_2013;
Hepburn_2016; MacKinnon_2014; McConachie_2014; McNally‐
Keehn_2013; Ohan_2016; Reaven_2009; Reaven_2012; Storch_2013;
Storch_2015; van Steensel_2015; White_2013; Wood_2009,
Wood_2015), and six studies involved student‐only CBT treatments
(Clarke_2017; Conaughton_2017; Luxford_2017; Murphy_2017; Pry-
or_2016; Sung_2011). One study (Sofronoff_2005) had two treatment
arms, with and without parental involvement.
Rather than a CBT intervention, Corbett_2017 used peer‐
mediated theater therapy in a group context to address social anxiety
by building the social‐emotional skills of participating adolescents,
while Piravej_2009 examined the benefits of Thai traditional massage
in a one‐on‐one context to internalizing, externalizing, and sleep
behaviors compared to the standard sensory integration treatment
available to participants.
In development since previous reviews of treatments for anxiety
in the ASD population, three studies examined the effectiveness of
CBT treatments (either published or newly developed) designed for
computer delivery (Conaughton_2017; Pryor_2016) or videoconfer-
encing (Hepburn_2016).
6.1.7 | Outcome measures
Across the 24 studies, 12 outcome measures of anxiety were used to
varying extent and with different respondents (clinician, parent,
child). Most of these measures are standardized, validated measures
of anxiety for use by clinicians (e.g., psychologists). The measures, as
indicated in Table 2, were the: Anxiety Disorders Interview Schedule
(ADIS: Silverman & Albano, 1996); the Child Anxiety Life Inter-
ference Scale (CALIS: Lyneham et al., 2013); the Childhood Anxiety
Sensitivity Index ‐ Anxiety (CASI‐Anx: Sukhodolsky et al., 2008);
Conners’ Parent Rating Scales—Anxiety (CPRS: Conners, 1989); the
Multidimensional Anxiety Scale for Children (MASC: March, Parker,
Sullivan, Stallings, & Conners, 1997); the Pediatric Anxiety Rating
Scale (PARS: RUPP Anxiety Study Group, 2002); the Revised Child
Anxiety and Depression Scales (RCADS: Chorpita, Moffitt, &
Gray, 2005); the Revised Children's Manifest Anxiety Scale—anxious
arousal subscale (RCMAS: Reynolds & Richmond, 1978); the Screen
for Child Anxiety Related Disorders (SCARED: Birmaher et al., 1999);
the Spence Child Anxiety Scale (SCAS: Spence, 1998); the State‐Trait
Anxiety Inventory for Children (STAI: Spielberger, Gorsuch, Lushene,
Vagg, & Jacobs, 1983); and the Social Worries Questionnaire (SWQ:
Spence, 1995). A summary of some of the key elements of the in-
cluded studies is presented in Table 2.
6.1.8 | Comparisons to previous reviews
Eight of the studies had not been included in previous reviews of
interventions for anxiety in the ASD population, predominantly due
to being published after the reviews were completed and because the
current review also included theses and dissertations that were ex-
perimental or quasi‐experimental studies. Table 3 presents the prior
reporting of studies in five previous systematic reviews undertaken
by Lang et al. (2010), Sukhodolsky et al. (2013), Kreslins et al. (2015),
Ung et al. (2015), and Perihan et al. (2019).
Table 4 lists the studies identified in the latest review by Perihan
et al. (2019) that were not included in this review with reasons for
noninclusion. As can be seen, the main reason for not including stu-
dies in this current review is their observational design.
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6.1.9 | Excluded studies
As indicated in Figure 1, 95 of the full‐text papers retrieved were
excluded from the current review: 19 did not report levels of anxiety
among participants, 16 had no outcome measure of anxiety, 15 did not
employ a control or comparison group, 10 had a participant age range
out of scope (and no potential for isolating participants within scope),
10 studies were classified as purely observational (pre‐ and post-
intervention in single group only), seven had no formal diagnosis of
ASD in their participants, six were secondary or follow‐up analyses of
previous studies that focused on aspect outside of inclusion criteria,
four did not include an intervention that met criteria, two were pro-
posals or study protocols only (no results were presented), and another
six did not provide sufficient information to satisfy the selection criteria
or had other issues. As summarized below and detailed in Appendices B
and C in the Supporting Information Material, these 95 excluded arti-
cles included those studies that might reasonably have been expected
to be included, such as those included in previous reviews, but which
did not meet the inclusion criteria of the current review:
• No anxiety present in participants=> 19 studies
• No measurement of anxiety outcomes=> 16 studies
• No control group=> 12 studies
• Age range out of scope=>10 studies
• Observational=> 10 studies
• No ASD diagnosis=> 7 studies
• Secondary study=> 5 studies
• No treatment=> 4 studies
• No comparison group=> 3 studies
• Out of scope=> 3 studies
• Not enough information=> 2 studies
• Protocol/proposal=> 2 studies
• Low quality=> 1 study
• Uses same data as a more recent included study=> 1 study
TABLE 3 Comparison of coverage of current review with previous published reviews of literature
Lang et al. (2010) Sukhodolsky et al. (2013) Kreslins et al. (2015) Ung et al. (2015) Perihan et al. (2019)








McConachie_2014 x x x





Reaven_2009 x x x
Reaven_2012 x x x x
Sofronoff_2005 x x x x x
Storch_2013 x x x x
Storch_2015 x
Sung_2011 x x x x
vanSteensel_2015 x
White_2013 x x x x
Wood_2009 x x x x x
Wood_2015 x x
Note: Studies included in other systematic reviews are presented in bold font, while those studies not included in previous reviews are presented in
normal font.
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6.2 | Risk of bias in included studies
6.2.1 | Selection bias
Thirteen of the studies performed adequate random sequence gen-
eration, either manually (using staff unrelated to the study, Cor-
bett_2017; Murphy_2017; Sung_2011; White_2013) or generated by
computer (Clarke_2017; Luxford_2017; Reaven_2012; Storch_2013;
Storch_2015; Wood_2009; Wood_2015). Block randomization pro-
cedures, stratified by demographic variables, were used in Fuji_2013,
McNally‐Keehn_2013, and Piravej_2009. Despite being identified as
randomized controlled trials, Chalfant_2007, Pryor_2016, and So-
fronoff_2005 did not provide suf ficient information about rando-
mization methods or procedures to assess potential bias.
It should be noted that four of the included studies were clas-
sified as quasi‐experimental studies, in that they included a com-
parison group but that allocation to groups was not random. Of the
quasi‐experimental studies, Hepburn_2016 used a pair‐wise match-
ing scheme for allocation to groups, Ohan_2016 claimed that the
order of enrollment “approximated” randomization, while Re-
aven_2009 had subjects act as their own WLCs.
Allocation concealment was not detailed in the majority of stu-
dies, although Conaughton_2017 and Wood_2017 maintaining con-
cealment by conducting baseline measures prior to randomization,
and McConachie_2014, Murphy_2017, and Storch_2015 by conceal-
ing treatment group allocation from the researchers and independent
evaluators throughout the studies.
6.2.2 | Performance and detection bias
Performance bias was universally high, due to the nature of the in-
terventions, as it was not possible to blind participants from their
treatment group allocation.
Detection bias was higher among studies that used outcome
measures based on the reports of participants themselves or their
parents (many of whom had also participated in family‐based in-
terventions), but lower in studies that used reports from clinicians
or teachers who were blinded to IT allocation. For those studies
that used multiple outcome measures from different informants, the
risk of performance bias was rated for each outcome measure
separately.
6.2.3 | Attrition bias
Attrition was rated as low in studies that had little to no attrition in
subjects, who evaluated the effect of attrition by comparing therapy
completer analyses with “Intent to Treat” analyses (i.e., analyses
using original samples and data imputation techniques), or who
compared the profile of study dropouts with completers with no
statistically significant differences found. Attrition bias was fairly low
across the studies, with only Ohan_2016 and Reaven_12 being rated
as high. Ohan_2006 reported that six of the treatment families failed
to complete their treatment (a loss of 25% of their sample), while
Reaven_12 reported a treatment‐completer sample of 47, but only
provided baseline data for 43 participants (IT = 20 and TAU = 23) and
used “last observation carried forward” imputation for missing data.
6.2.4 | Reporting bias
There was no evidence or suggestion of reporting bias in any of the
studies. However, a risk of bias assessment was undertaken by rating
each study as high, unclear, or low risk of bias against five attributes.
A summary of the risk of bias assessment for the included studies is
presented alongside each forest‐plot. In addition, publication bias
was assessed using a funnel plot.
6.3 | Synthesis of results
6.3.1 | Treatment efficacy
Twenty‐four studies reported outcome measures from one or
more informants (clinicians, parents, student self‐reports), with
TABLE 4 Studies that were not included in this review but were included in Perihan et al. (2019)
Studies n Reasons for exclusion
Drmic, Aljunied, and Reaven (2017) 44 Observational study
Ehrenreich‐May et al. (2014) 20 The BIACA intervention was already covered under the Storch 2015 paper (RCT study) for a
larger age group (11 to 16 years); Also, no control group
Maskey, Lowry, Rodgers, McConachie, and
Parr (2014)
9 Observational study
Ooi et al. (2008) 6 Observational study (pre‐post design only, no control group)
Scarpa and Reyes (2011) 11 No concurrent diagnosis of anxiety problems and no appropriate measure of anxiety as an
outcome
Thomson, Burnham Riosa, and Weiss (2015) 13 Observational (no control group)
Weiss, Viecili, and Bohr (2014) 18 Observational study
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60 informant reports in total, along with several teacher reports
(see Table 2). These studies involved 1,020 participants (524 in
the treatment group and 496 in the control group—note that
participants in pre‐post studies are counted twice). Rather than
averaging all reports within each study across different measures
to derive an overall treatment effect, the reports with lower risk
of bias were selected. For half of the studies, the clinician report
was used. For seven of the studies, the averaged parent‐ and
student‐reported SCAS (six instances) or SCARED (one instance)
were used. For the other five studies, a parent‐only or student‐
only report was used. A random effects meta‐analysis of the 24
studies revealed a statistically significant treatment effect for
interventions for reducing anxiety in mainstream school‐aged
students with ASD. The overall SMD was d = −0.83 (95% CI:
−1.16, −0.51; z = −5.03, p < .01) which can be considered a very
high effect. Based on these measures, the anxiety levels in the
treatment groups were significantly lower than those seen in the
control groups at posttreatment.
Considerable heterogeneity across the studies and assessments
was detected (I2 = 83%). Figure 2 presents a forest plot illustrating
the results. Visual inspection of the both the forest plot and the
funnel plot, as presented in Figure 3, identified the SMD score re-
ported by Chalfant_2007 as an outlier. A sensitivity analysis was
carried out by removing this study, reducing the overall SMD to −0.71
(95% CI: −0.97, −0.46; z = −5.42, p < .01). While removal of the outlier
did reduce the overall effect size, the difference between treatment
and control conditions at posttreatment remained very high and
statistically significant.
6.3.2 | Clinician reported outcome measures
Thirteen studies involving a total of 526 students (267 in the
treatment condition and 259 in the control condition) reported
one or more clinician‐reported outcome measure, with 18 reports
in total. The three measures used by clinicians were the ADIS
F IGURE 2 Forest plot of studies included in the meta‐analysis, with risk of bias summary
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(A, 12 instances), the CASI‐Anx (C, 2 instances), and the PARS (P,
4 instances). All studies reported greater improvements post-
treatment in the treatment condition compared to the control
condition, although Murphy_2017) reported nonsignificant mixed
results. The overall SMD was d = −0.84 (95% CI: −1.15, −0.54;
z = −5.43, p < .01) which can be considered a very high effect,
potentially equivalent to 10 months developmental progress.
Based on these measures, the anxiety levels in the treatment
groups were significantly lower than those seen in the control
groups at posttreatment. Considerable heterogeneity across the
studies and assessments was detected (I2 = 70%). Figure 4 pre-
sents a forest plot illustrating the results.
6.3.3 | Parent reported outcome measures
Nineteen studies reported one or more parent reported outcome
measures, with 21 reports in total. These studies involved 819
participants (412 in the treatment group and 407 in the control
group). The five measures used with parents were the SCAS (S, 11
instances), the MASC (M, 5 instances), SCARED (D, 3 instances),
CALIS (C, 1 instance), and the CPRS (N, 1 instance). The overall
SMD was d = −0.68 (95% CI: −1.05, −0.31); z = −3.64, p < .01), in-
dicating that the difference between the treatment and control
groups at posttreatment reached significance. There was sig-
nificant heterogeneity across the included studies and measures
(I2 = 85%). Figure 5 presents a forest plot of the results, along
with a summary of the risk of bias. Like other systematic reviews
(e.g., Kreslins et al., 2015), the SMD reported by Chalfant_2007
was assessed as an outlier, being substantially higher than the
others reported. A sensitivity analysis was carried out. Once this
outlier was removed, the overall SMD decreased to −0.53 (95%CI
−0.76, −0.31; z = −4.73, p < .01). Although the summary estimate
decreased following removal of the outlying study, the high
treatment effect remained statistically significant and potentially
equivalent to 7‐month developmental progress.
6.3.4 | Student self‐reported outcome measures
Self‐reported outcome data from 734 student participants (370 in
the treatment group and 364 in the control group) from 21 outcome
reports across 17 studies were synthesized. The main student out-
come measure used by 10 studies was the SCAS (S). The SCARED (D),
MASC (M), RCMAS (R), and RCADS (V) had each been used by two of
the studies, while the CALIS (L), STAI (T), and SWQ (W) had each
been used by one of the studies. The overall SMD was d = −0.58 (95%
CI: −0.95, −0.21; z = −3.06, p = .002) with a significant difference (high
effect size, equivalent to 7‐month progress) between the treatment
and control conditions at posttreatment. Figure 6 presents a forest
plot of the student results. There were high levels of heterogeneity
across the studies (I2 = 85%). The two SMD scores reported by
Chalfant_2007 were again identified as outliers and a sensitivity
analysis was undertaken. Removal of this study reduced the overall
SMD to −0.35 (95% CI: −0.55, − 0.15; z = −3.41, p < .01). This differ-
ence between treatment and control conditions at posttreatment of a
moderate effect was significant and equivalent to 4‐month progress.
6.3.5 | Moderator analysis
Also of interest in this study, was the potential moderating effects of a)
family involvement in sessions and b) the individual or group nature of
sessions. These two moderators were analyzed to help address the lack
of similar investigations in previous reviews published, and to draw
comparison to the most recent review by Perihan et al. (2019), which
did consider the potential moderator of parental involvement.
6.3.6 | Family involvement
Two groups were created based on family involvement, in order to
compare the outcomes of treatments with parental involvement (n=15,
excluding outlier Chalfant_2007) to treatments without parental
F IGURE 3 Funnel plot of the 24 included
studies
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involvement (n=9). It should be noted that the Piravej et al. (2009) study
involving Thai massage was categorized as being without family in-
volvement even though for safety reasons, the parent was present in the
room. Similar to Perihan et al.'s (2019) findings, treatments that had
family involvement resulted in a larger overall effect size than treatments
without parental involvement, a difference equivalent to 2‐month addi-
tional progress. The SMD with family involvement yielded a very high
significant effect size of d=−0.74 (95% CI: −1.06, −0.42; z=−4.55,
p< .01). In comparison, the SMD without family involvement resulted in a
high significant effect size of d=−0.60 (95% CI: −1.03, −0.17; z=−2.73,
p= .006). There were high levels of heterogeneity across the two groups
of studies (I2 = 70% with involvement; 75% without involvement).
Figure 7 presents a forest plot of the moderating effect of family
involvement.
6.3.7 | Individual or group treatment
In order to compare the potential moderating effect of treatment
format, two groups of studies were formed and assessed based on
whether the treatment was administered on an individual basis (n = 9),
like the Thai massage (Piravej et al., 2009), or in a group setting
(n = 14), such as the peer‐mediated, theater‐based intervention
(Corbett et al., 2017). The forest plot presented in Figure 8 suggests
that individually based treatments resulted in a larger overall effect
size than group‐based treatments, a difference equivalent to 7‐month
additional progress. The SMD yielded a very high significant effect size
of d = −1.24 (95% CI: −1.75, −0.74; z = −4.87, p < .01). In comparison,
the SMD for group treatments resulted in a moderate significant effect
size of d = −0.37 (95% CI: −0.54, −0.19; z = −4.10, p < .01). There was a
high level of heterogeneity across studies involving individual treat-
ments (I2 = 80%) and a low level of heterogeneity across the studies
involving group treatments (I2 = 0%).
7 | DISCUSSION
7.1 | Summary of main results
Eighteen RCTs and six quasi‐experimental studies evaluating the
effects of interventions targeting anxiety for individuals of
F IGURE 4 Forest plot of clinician‐reported outcome measures with risk of bias summary
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mainstream school age—with participants in some study also in-
volving slightly younger and slightly older young people—with ASD
were included in this review. The results of the meta‐analyses
provide some evidence that psychoeducational interventions for
anxiety, predominantly CBT, may improve anxiety symptoms
(SMD = −0.71, p < .01, after removal of outliers) for mainstream
school‐aged children with ASD, ultimately reducing the number of
diagnoses of anxiety disorders for some participants. More fa-
vorable outcomes for the treatment group compared to the con-
trol groups were recorded across the majority of studies, with an
overall moderate effect size. Outcomes varied by respondent
group, however, with larger effect sizes recorded when outcome
measures were based on clinician reports (SMD = −0.84, p < .01),
compared to parent reports (SMD = −0.53, p < .01). Difference be-
tween treatment and control groups were smaller again, although
still significant, when the participants reported outcomes them-
selves (SMD = −0.35, p = .001). These differences between re-
spondents have been noted elsewhere, and may introduce bias to
the results (underestimating the effects). Moderators indicated
larger effects for treatments that involved parents (SMD = −0.74,
p < .01) than for student‐only interventions (SMD = −0.60, p < .01).
Treatments that were administered individually one‐on‐one
(SMD = −1.24, p < .01), indicated larger effects than for treat-
ments delivered at a group‐level (SMD = −0.37, p < .01).
7.2 | Overall completeness and applicability of
evidence
The large number of studies meeting our original inclusion criteria
was of sufficient size to warrant restricting the results to a meta‐
analysis of RCTs and quasi‐experimental studies. Data on the primary
outcome—anxiety—was gathered using a variety of instruments. Al-
though this may be seen as a source of variability and imprecision in
the results, all of the instruments used adhered to published re-
commendations for reliability and quality (Lecavalier et al., 2014;
Wigham & McConachie, 2014) and have been analyzed in previous
reviews (Kreslins et al., 2015).
F IGURE 5 Forest plot of parent‐reported outcome measures with risk of bias summary
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The majority of included studies were located in developed,
Western countries, and the interventions conducted in clinical set-
tings attached to medical or university institutions. Only two studies
examined home‐based interventions and two interventions were
conducted in schools. This is probably an accurate reflection of the
state of research of this nature, but did impact on our ability to
examine intervention settings as a source of variability in effective-
ness. Almost twice as many studies involved treatments with par-
ental involvement and there tended to more studies that involved
treatments delivered in a group format.
Similarly, while a small number of studies included outcome
measures based on the reports of teachers, these were usually
limited by significant attrition and thus recommended extreme
caution in interpreting results, or did not report results for this
respondent group. Given our proposed focus on real‐world set-
tings, the inability to evaluate the effectiveness of interventions
based on the view of teachers is an unfortunate limitation to this
review.
Only two of the included studies used an intervention other than
CBT. While CBT is a more widely accepted intervention for anxiety,
including for participants with ASD, it was not our intention to limit
the studies to CBT. It is possible that the focus on RCTs and quasi‐
experimental studies unintentionally limited coverage of studies
using more recently developed interventions, which may still be at
the stage of case studies or observational studies.
Finally, while it was not a requirement for inclusion in the current
review, the majority of the studies limited participants to individuals
with functioning above a certain level of cognitive ability, most com-
monly a full scale or verbal IQ of 70 or above, or in one case, the ability
to read and write (in English) at an 8‐year‐old level as a minimum. These
restrictions were explained as being due to the demands of CBT. Only
three studies did not place restrictions (either explicitly or de facto by
requiring that participants be attending a mainstream school) on the
cognitive functioning of participants, and two of these employed
cognitive‐behavioral therapy‐based interventions (Hepburn_2016;
MacKinnon_2014). Neither study examined the potential impact of
F IGURE 6 Forest plot of self‐reported outcome measures with risk of bias summary
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cognitive functioning on anxiety outcomes and did not report outcomes
for participants grouped by cognitive functioning level. This does limit
our ability to determine what effects these types of interventions might
have on individuals with ASD and intellectual disability. This limitation
has been noted in other research focusing on the effectiveness of
psychosocial interventions in populations with ASD (Kreslin et al., 2015).
7.3 | Quality of the evidence
The quality of the evidence can be considered moderate. Results in
favor of treatment groups compared to control groups were fairly
consistent across the included studies, although a number noted
mixed nonsignificant results when using reports from more than one
respondent (particularly, when using parent and self‐reports).
Overall, the number of low and questionable assessments of risk
outweighed those of high risk. There are, however, issues around the
variety of outcome measures and informants that may introduce
imprecision to the overall measures of effectiveness and thus should
be considered.
The effectiveness of the interventions was generally
stronger for clinician (mostly blinded) reports but lower among
parent and self‐report measures. Issues with self‐report in ASD
children have been noted in other reviews, with both
Kreslins et al. (2015) and Sukhodolsky et al. (2013) reporting
lower effect sizes when using self‐report as the outcome
measure of anxiety. It is difficult to identify whether these dif-
ferences emerge from difficulties in interpreting the questions
on the outcome measures or may reflect a lower level of insight
into their own symptoms in this particular population. It is worth
noting that none of the self‐report outcomes measures had
been designed, modified or normed for use with children
with ASD.
Due to the nature of the interventions and the selected
outcome measures, the risk of performance and detection bias
were higher for some outcome measures (parent and self‐reports)
compared to others. Apart from Clarke_2017, which was a
school‐based intervention and included a parent report as an
outcome measure, parents were aware of the treatment group
their child was assigned to. Accordingly, the nature of the
F IGURE 7 Forest plot comparing treatments with and without family involvement
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interventions made it impossible to blind participants themselves
to treatment status, so all self‐reports may reflect high perfor-
mance and detection bias. Given this high risk of bias, the results,
particularly those based on parent or self‐report should be in-
terpreted with caution.
7.4 | Limitations and potential biases in the review
process
Although the systematic nature of the review process followed
here, decreases the potential for bias, risks of bias in the review
process remain. The greatest risk of bias of this review was the
selection of studies, specifically, the decision to limit the inclusion
criteria to randomized control studies and quasi‐experimental
studies. The inclusion of RCTs alongside quasi‐experimental
studies, and studies of CBT alongside other interventions, may
have introduced variability to the estimates of effectiveness and
is thus a potential limitation to the results.
7.5 | Agreements and disagreements with other
studies or reviews
The results of this review and meta‐analysis suggest there is mod-
erately strong evidence for the effectiveness of psychosocial inter-
ventions, such as CBT, in reducing anxiety amongst mainstream
school‐aged children with ASD. This is consistent with the conclu-
sions of similar reviews (Kreslins et al., 2015; Sukhodolsky
et al., 2013; Ung et al., 2015), although these reviews focused solely
on CBT, while this review included other approaches.
The results of the current review do differ from previous re-
views, however, in finding that the interventions were effective even
from the point of view of the children participating in them. This
meta‐analysis found an SMD of −0.35, p = .001, when using self‐
report as the outcome measure, compared to d = −0.65 (p = .10) in
Kreslins et al. (2015) and d = −0.68 (p = .12) in Sukhodolsky et al.
(2013). The moderator of family involvement (SMDwith = −0.74,
p < .01; SMDwithout = −0.60, p < .01) was in keeping with Perihan
et al.'s (2019) findings (gwith = −0.85, p < .05; gwithout = −0.34, p < .05).
F IGURE 8 Forest plot comparing treatments that involve individual or group participation
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The results of this review are, thus, in line with previous reviews,
and suggest that interventions can have positive effects on the ex-
periences of young people with ASD and anxiety, although more
research is needed to identify the underlying cause or causes of the
discrepancy in effectiveness depending on the respondent.
8 | AUTHORS ’ CONCLUSIONS
8.1 | Implications for practice and policy
CBT in various forms is one of the most widely used psychoeduca-
tional interventions to improve the anxiety symptoms of mainstream
school‐aged children with ASD. The results of the meta‐analyses in
this review suggest that children who participate in interventions
based on CBT, whether modified specifically for those with ASD or
not, may make significant gains in terms of reduction of anxiety
symptoms, in some cases no longer meeting criteria for a primary
anxiety diagnosis or comorbid diagnoses of other anxiety disorders.
Evidence in support of other psychoeducational interventions, such
as massage and theater therapy to address social anxiety, is more
limited, not just due to the popularity of CBT but also due to the
quality of the smaller number of non‐CBT studies available.
While the review does indicate that interventions based on the
principles of CBT may be effective for reducing anxiety, the variety of
curricula (and modifications made to those curricula) used in the
studies included may have confounded the results. There were not a
sufficient number of studies that employed the same curricula (even
those that used the same base curricula may have made different
modifications) to allow for a direct comparison of effects between
curricula, and so it is not possible to provide recommendations as to
whether one CBT curricula might be more effective than another, or
indeed whether any one program may be more effective with a
certain subgroup of participants (e.g., individuals with an intellectual
disability, ADHD). However, as CBT provides an overarching theo-
retical framework upon which curricula are based, different pro-
grams that are grounded in the principles of CBT should, at least in
principle, have similar degrees of effectiveness.
8.2 | Implications for research
The results of this review suggest that while there is evidence that CBT
is an effective behavioral treatment for anxiety in some children and
youth with ASD, there is still work to be done in terms of identifying the
characteristics of these interventions that contribute to their effec-
tiveness and identifying the characteristics of participants who are more
likely to respond to such interventions. The results suggest that group
therapies are less effective than individual one‐on‐one therapies and
that having the family involved is more effect at reducing anxiety than
not. Many of the studies reviewed here included modifications to
published curricula that were hypothesized to improve the acceptance
and effectiveness of the interventions for children with ASD, such as
visual aids, highly structured sessions and flexibility around the number
of length of sessions. It is unclear what effect, if any, the use of different
curricula and modifications had on the results of this review. Future
research with larger samples and active control groups are necessary to
allow direct comparisons of the different curricula and identification of
the characteristics of participants (e.g., age, social competence, level of
language ability, and communication skills) for whom the intervention is
most likely to be of benefit.
Research should also focus on expanding the cognitive func-
tioning levels of participants (i.e., including individuals with below
average cognitive abilities) so as to identify the characteristics of
interventions that can be employed with children and adolescents
with ASD and lower levels of general functioning or language ability.
The trend of somewhat weaker effects of interventions when
outcomes are measured via self‐report, noted here and in similar
reviews (e.g., Kreslins et al., 2015; Sukhodolsky et al., 2013) warrants
further investigation. It may be that this trend reflects actual dif-
ferences in the perceived benefits of interventions between clin-
icians, parents and children. However, it is troubling to assume that
the more valid assessment of a child's experience is an external ob-
server, whether that be a clinician or a parent. Other factors, such as
the development of self‐awareness and understanding of health
concepts, have been suggested by other researchers as potential
sources of inconsistency in self‐reports with children, and more
particularly with children with ASD (Kreslins et al., 2015).
Some suggest that individuals with ASD can manifest in ways
that are idiosyncratic and not aligned with the ways that anxiety
presents in non‐ASD populations (Kerns & Kendall, 2012; Kerns
et al., 2016; Uljarević et al., 2018). Certain traits and behaviors, such
as social avoidance or rigid, ritualistic behaviors, can be a manifes-
tation of both core ASD symptomatology and indicative of comorbid
anxiety (Kerns et al., 2015). However, with rare exception (see
Rodgers et al., 2016), instruments used to measure anxiety in ASD
have been develop for non‐ASD populations. Such instruments are
not designed to be sensitive to distinguishing atypical anxiety pre-
sentations in ASD populations nor distinguish whether a particular
symptom is a presentation of ASD or comorbid anxiety—nor should
they be. Nevertheless, current instruments might at the same time
both over‐ and undersample anxiety problems associated with ASD.
What may be of importance, however, is whether symptoms are
more or less responsive to intervention among populations with
anxiety alone versus those with ASD and comorbid anxiety, which
might be more ingrained. Accordingly, the development of instru-
ments for anxiety symptoms that are specifically designed for and
normed with ASD population may be of use.
It may be worth considering the input of those with ASD in the
design and modifications of interventions for anxiety. As with other
groups, it is important to involve people with ASD in the design and
modification of interventions designed for them, including those
targeting anxiety. People with ASD are likely to be able to shed
important insight into the strengths and weaknesses of different
approaches, and also to the specific skills required of therapists
working with this population. Finally, it is imperative to develop
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instruments that are valid in assessing treatment effects in people
with ASD. Assessing participants’ satisfaction with interventions is
not enough, as they are unlikely to have been exposed to multiple
interventions at the same time and thus be able to make direct
comparisons. Instead, children and adolescents with ASD should be
able to provide formative feedback and be involved in redesign.
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